G.Barekat Pharm (XTEH:BRKT1) Treasury Stock : IRR-9,680 Mil (As of Mar. 2017)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. G.Barekat Pharm's treasury stock for the quarter that ended in Mar. 2017 was IRR-9,680 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

G.Barekat Pharm Treasury Stock Historical Data

The historical data trend for G.Barekat Pharm's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Treasury Stock Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Treasury Stock

-9,680.00

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Treasury Stock	-	-9,680.00

G.Barekat Pharm Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines